- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.73 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x H2U: 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE(Non-covalent)
H2U.2: 16 residues within 4Å:- Chain A: P.95, L.96, R.102, A.103, F.117, N.119, D.120, F.121, V.150, N.195, C.202, S.203, N.204, H.208, Q.210
- Ligands: G1P.34
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:P.95
- Hydrogen bonds: A:A.103, A:N.119, A:D.120, A:D.120, A:Q.210, A:Q.210
- Water bridges: A:N.195, A:N.195, A:N.195, A:N.204
- Salt bridges: A:H.208
- pi-Stacking: A:F.121
H2U.20: 16 residues within 4Å:- Chain B: P.95, L.96, R.102, A.103, F.117, N.119, D.120, F.121, V.150, N.195, C.202, S.203, N.204, H.208, Q.210
- Ligands: G1P.18
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:P.95
- Hydrogen bonds: B:A.103, B:N.119, B:N.119, B:D.120, B:D.120, B:Q.210
- Water bridges: B:N.195, B:N.195, B:S.203
- Salt bridges: B:H.208
- pi-Stacking: B:F.121
- 28 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 7 residues within 4Å:- Chain A: R.281, H.282, V.283, R.284, E.288, N.336
- Ligands: EDO.9
Ligand excluded by PLIPEDO.4: 4 residues within 4Å:- Chain A: S.130, S.143, R.145
- Ligands: EDO.10
Ligand excluded by PLIPEDO.5: 8 residues within 4Å:- Chain A: R.70, P.272, L.349, K.356, Q.368, R.369, D.370, L.371
Ligand excluded by PLIPEDO.6: 5 residues within 4Å:- Chain A: R.284, R.285, A.331, G.332, W.335
Ligand excluded by PLIPEDO.7: 4 residues within 4Å:- Chain A: Q.140, K.142
- Chain B: Y.56, W.63
Ligand excluded by PLIPEDO.8: 5 residues within 4Å:- Chain A: E.237, P.238, M.241, H.282
- Ligands: EDO.9
Ligand excluded by PLIPEDO.9: 4 residues within 4Å:- Chain A: H.282, N.336
- Ligands: EDO.3, EDO.8
Ligand excluded by PLIPEDO.10: 6 residues within 4Å:- Chain A: S.130, P.131, A.141, K.142, S.143
- Ligands: EDO.4
Ligand excluded by PLIPEDO.11: 5 residues within 4Å:- Chain A: M.241, S.244, R.245, L.248, R.280
Ligand excluded by PLIPEDO.12: 6 residues within 4Å:- Chain A: D.174, A.177, S.178, E.181, P.287, R.294
Ligand excluded by PLIPEDO.13: 3 residues within 4Å:- Chain A: E.378, R.381, A.382
Ligand excluded by PLIPEDO.14: 5 residues within 4Å:- Chain A: D.112, H.154, P.155, W.156
- Ligands: EDO.17
Ligand excluded by PLIPEDO.15: 11 residues within 4Å:- Chain A: F.153, L.161, W.176, E.194, C.209, M.301, L.305, Y.318, M.320, W.322, Y.344
Ligand excluded by PLIPEDO.16: 4 residues within 4Å:- Chain A: R.245, Q.246, L.249
- Chain B: H.136
Ligand excluded by PLIPEDO.17: 3 residues within 4Å:- Chain A: R.89, W.156
- Ligands: EDO.14
Ligand excluded by PLIPEDO.21: 10 residues within 4Å:- Chain B: D.118, N.119, P.122, L.124, Q.125, P.126, G.146, V.147, C.148, K.149
Ligand excluded by PLIPEDO.22: 7 residues within 4Å:- Chain B: P.188, L.217, P.326, T.327, G.328, S.329, W.335
Ligand excluded by PLIPEDO.23: 6 residues within 4Å:- Chain B: D.112, H.154, P.155, W.156, E.168
- Ligands: EDO.24
Ligand excluded by PLIPEDO.24: 8 residues within 4Å:- Chain B: H.154, W.156, V.159, L.163, M.164, S.165, E.168
- Ligands: EDO.23
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain A: F.139
- Chain B: R.250, E.252, R.253, F.267
Ligand excluded by PLIPEDO.26: 8 residues within 4Å:- Chain B: R.70, P.272, L.349, K.356, Q.368, R.369, D.370, L.371
Ligand excluded by PLIPEDO.27: 3 residues within 4Å:- Chain B: S.130, S.143, R.145
Ligand excluded by PLIPEDO.28: 5 residues within 4Å:- Chain B: E.237, P.238, M.241, E.242, R.245
Ligand excluded by PLIPEDO.29: 4 residues within 4Å:- Chain B: H.90, P.98, G.99, Q.110
Ligand excluded by PLIPEDO.30: 8 residues within 4Å:- Chain B: R.281, H.282, V.283, R.284, R.285, E.288, N.336
- Ligands: EDO.32
Ligand excluded by PLIPEDO.31: 3 residues within 4Å:- Chain B: P.88, R.89, D.158
Ligand excluded by PLIPEDO.32: 3 residues within 4Å:- Chain B: H.282, N.336
- Ligands: EDO.30
Ligand excluded by PLIPEDO.33: 2 residues within 4Å:- Chain B: R.89, W.156
Ligand excluded by PLIP- 2 x G1P: 1-O-phosphono-alpha-D-glucopyranose(Non-covalent)
G1P.18: 14 residues within 4Å:- Chain A: K.356, F.357, V.359, G.360, Y.361, E.362, Q.368
- Chain B: F.193, N.195, G.201, C.202, Q.210, W.212
- Ligands: H2U.20
10 PLIP interactions:6 interactions with chain A, 4 interactions with chain B- Hydrogen bonds: A:K.356, A:F.357, A:F.357, A:Y.361, B:N.195, B:Q.210
- Water bridges: A:R.70, A:Q.368, B:N.119, B:Q.210
G1P.34: 14 residues within 4Å:- Chain A: F.193, N.195, G.201, C.202, Q.210, W.212
- Chain B: K.356, F.357, V.359, G.360, Y.361, E.362, Q.368
- Ligands: H2U.2
10 PLIP interactions:7 interactions with chain B, 3 interactions with chain A- Hydrogen bonds: B:K.356, B:F.357, B:F.357, B:Y.361, B:E.362, A:N.195, A:G.201, A:Q.210
- Water bridges: B:R.70, B:R.70
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McCorvie, T.J. et al., Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase. Hum.Mol.Genet. (2016)
- Release Date
- 2016-03-30
- Peptides
- Galactose-1-phosphate uridylyltransferase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.73 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x H2U: 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE(Non-covalent)
- 28 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x G1P: 1-O-phosphono-alpha-D-glucopyranose(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McCorvie, T.J. et al., Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase. Hum.Mol.Genet. (2016)
- Release Date
- 2016-03-30
- Peptides
- Galactose-1-phosphate uridylyltransferase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
A